Results 201 to 210 of about 4,993,323 (339)

Effectiveness of Homoeopathic Treatments for Sleep Disorders in Children and Adolescents: A Systematic Review According to the Principles of Evidence-Based Medicine. [PDF]

Children (Basel)
Upreti K, Frass M.
europepmc   +1 more source

Evidence based medicine: philosophical [PDF]

, 2003
Sehon, S., Stanley, Donald
core  

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Single-Authored Systematic Reviews and Meta-Analyses: A Bibliometric Analysis of Trends and Alignment with Evidence-Based Medicine Guidelines. [PDF]

J Multidiscip Healthc
Shamsi A, Wang T, Bai T, Kadkhodaei Z, Heidari H, Dakhesh S.   +5 more
europepmc   +1 more source

Editorial commentary: Evidence-based medicine during a pandemic

, 2021
Juan Farina, Kiera Liblik, Adrián Baranchuk   +2 more
openalex   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Evaluating search quality and article choice in evidence-based medicine assignments of preclinical students. [PDF]

J Med Libr Assoc
Magro J, Plovnick C, Nicholson J.
europepmc   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Critique on "Evaluation of Sex-Based Differences in the Prescription of the Combination of Evidence-Based Medicine After the Occurrence of an Acute ST-Elevation Myocardial Infarction". [PDF]

Clin Cardiol
Naseer M, Haider S, Rehman T.
europepmc   +1 more source

Principles of drug therapy for acute bacterial rhinosinusitis: from evidence-based medicine to practice

, 2018
D. S. Pshennikov, И. Б. Анготоева   +1 more
openalex   +1 more source